Investor Presentation • Mar 3, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
RESULTS PRESENTATION
3 rd March 2025


This document contains forward looking statements which reflect the Board of Directors' current views and estimates. The forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures, the effects of a pandemic or epidemic or a natural disaster, or war and regulatory developments.
You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Company expressly disclaims any obligation or undertaking to publicly update or revise any forward-looking statements other than as required by applicable law.






















In €m / % of revenue



| FY 20241.) | CY 20232.) | |
|---|---|---|
| Organic Growth | (0.7)% | 15.2% |
| EBITDA % | 14.0% | 13.0% |
Revenue growth:
Margin expansion:

| FY 20241.) | CY 20232.) | |
|---|---|---|
| Organic Growth | 3.7% | 11.2% |
| EBITDA % | 19.8% | 20.6% |
Revenue growth:
Margin expansion:
In €m / % of revenue

17
| Levers | Mid-Term Targets 2023-25 | FY 2024 Results | ||
|---|---|---|---|---|
| Manufacturing continuous improvement program |
2-3% cost1.) efficiency YoY | ▪ | Manufacturing efficiency: | on track |
| SIMPLEX – recipe standardisation & Procurement leverage |
€26-36m costs optimisation | ▪ | Costs optimisation: | €36m |
| E2E processes optimisation | Fixed costs growth @ 30-40% of organic growth |
▪ | Fixed cost growth: | above - driven by higher labour costs |

Free cash flow evolution (in €m)


Trade Working Capital as % of TTM revenue1.)


20
Total net debt (incl. hybrid & leases) in €m




ROIC %

ROIC improvement driven by:
EPS (in € cent)






Continuation of successful strategy

Bake-off market outlook update






| 12-month | 17-month | |
|---|---|---|
| in €m | December 2024 | December 2023 |
| Revenue | 2,194.5 | 3,046.0 |
| Cost of sales | (1,443.9) | (2,069.4) |
| Distribution expenses | (281.4) | (383.1) |
| Gross profit | 469.2 | 593.5 |
| Selling expenses | (100.6) | (128.9) |
| Administration expenses | (178.6) | (244.8) |
| Operating profit | 190.0 | 219.8 |
| Financing costs, net | (31.7) | (35.9) |
| RCF termination costs | (4.0) | – |
| Profit before income tax | 154.3 | 183.9 |
| Income tax expense | (24.7) | (23.4) |
| Profit for the period | 129.6 | 160.5 |
| Hybrid dividend | (29.5) | (64.4) |
| Profit used to determine EPS | 100.1 | 96.1 |

| 12-month | 17-month | |
|---|---|---|
| EBITDA (in €m)1 | December 2024 | December 2023 |
| ARYZTA Europe | 271.5 | 330.4 |
| ARYZTA Rest of World | 49.4 | 70.4 |
| Total Group | 320.9 | 400.8 |
| 12-month | 17-month | Change | |
|---|---|---|---|
| EBITDA margin1 | December 2024 | December 2023 | bps |
| ARYZTA Europe | 14.0% | 12.2% | 180 bps |
| ARYZTA Rest of World | 19.8% | 20.2% | (40) bps |
| Total Group | 14.6% | 13.2% | 140 bps |
1 See glossary on slide 42 for definitions of financial terms and references.

| 17-month | ||
|---|---|---|
| 12-month | December | |
| in €m | December 2024 | 2023 |
| EBITDA | 320.9 | 400.8 |
| Working capital movement | 31.1 | (16.2) |
| Working capital movement from debtor securitisation | 3.0 | 24.6 |
| Capital expenditure | (94.3) | (91.8) |
| Net payments on lease contracts | (37.9) | (50.9) |
| Proceeds from sale of fixed assets | 0.9 | 4.5 |
| Restructuring-related cash flows | (0.4) | (3.6) |
| Dividends paid on hybrid instruments | (34.7) | (65.7) |
| Interest and income tax paid, net | (56.6) | (60.0) |
| Other | 5.8 | (2.1) |
| Free cash flow | 137.8 | 139.6 |

| 12-month | 17-month | |
|---|---|---|
| in €m | December 2024 | December 2023 |
| Net debt | (739.3) | (490.8) |
| Hybrid Instrument Funding | (154.9) | (510.0) |
| Total net debt and hybrid funding | (894.2) | (1,000.8) |

| December | December | |
|---|---|---|
| in €m | 2024 | 2023 |
| Average invested capital | 1,188.5 | 1,225.3 |
| NOPAT1 | 158.8 | 150.1 |
| ROIC1 | 13.4% | 12.3% |
1 See glossary on slide 42 for definitions of financial terms and references.

| 12-month | |||
|---|---|---|---|
| 12-month | December 2023 | ||
| in €m | December 2024 | Unaudited | Change % |
| Revenue | 2,194.5 | 2,192.7 | 0.1% |
| Cost of sales | (1,443.9) | (1,471.8) | 1.9% |
| Distribution expenses | (281.4) | (271.3) | (3.7)% |
| Gross profit | 469.2 | 449.6 | 4.4% |
| Selling expenses | (100.6) | (91.4) | (10.1)% |
| Administration expenses | (178.6) | (182.3) | 2.0% |
| Operating profit | 190.0 | 175.9 | 8.0% |
| Financing costs, net | (31.7) | (29.3) | (8.2)% |
| RCF termination costs | (4.0) | – | - |
| Profit before income tax | 154.3 | 146.6 | 5.3% |
| Income tax expense | (24.7) | (20.9) | (18.2)% |
| Profit for the period | 129.6 | 125.7 | 3.1% |
| Hybrid dividend | (29.5) | (44.1) | 33.1% |
| Profit used to determine EPS | 100.1 | 81.6 | 22.7% |
| Weighted average ordinary shares used to determine EPS (in millions) | 996 | 995 | 0.1% |
| Diluted earnings per share | 10.0 | 8.2 | 22.5% |

| ARYZTA | ARYZTA | ||
|---|---|---|---|
| in €m | Europe | Rest of World | Total Group |
| Revenue | 1,945.1 | 249.4 | 2,194.5 |
| Organic growth | (0.7%) | 3.7% | (0.2%) |
| Disposals movement | – | – | – |
| Currency movement | 0.5% | (1.7%) | 0.3% |
| Total revenue movement | (0.2%) | 2.0% | 0.1% |
All movements represent the revenue growth comparing the 12-month financial period ended December 2024 to the 12-month prior period ended December 2023

| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | |
|---|---|---|---|---|---|
| ARYZTA Europe | |||||
| Volume % | 0.8% | (0.7)% | 3.4% | (2.4)% | 0.2% |
| Price % | - | (1.6)% | (1.5)% | - | (0.8)% |
| Mix % | (0.5)% | (0.2)% | (0.1)% | 0.1% | (0.1)% |
| Organic growth % | 0.3% | (2.5)% | 1.8% | (2.3)% | (0.7)% |
| ARYZTA Rest of World | |||||
| Volume % | (4.2)% | 4.2% | 2.2% | 3.0% | 1.3% |
| Price % | 2.7% | 2.8% | 1.8% | 1.9% | 2.3% |
| Mix % | 0.2% | - | 0.1% | (0.1)% | 0.1% |
| Organic growth % | (1.3)% | 7.0% | 4.1% | 4.8% | 3.7% |
| ARYZTA Group | |||||
| Volume % | 0.2% | (0.2)% | 3.2% | (1.8)% | 0.3% |
| Price % | 0.3% | (1.1)% | (1.1)% | 0.2% | (0.4)% |
| Mix % | (0.4)% | (0.2)% | (0.1)% | 0.1% | (0.1)% |
| Organic growth % | 0.1% | (1.5)% | 2.0% | (1.5)% | (0.2)% |

| 12-month | |||
|---|---|---|---|
| 12-month | December 2023 | ||
| EBITDA (in€m)1 | December 2024 | Unaudited | % Change |
| ARYZTA Europe | 271.5 | 254.1 | 6.8% |
| ARYZTA Rest of World | 49.4 | 50.4 | (2.0)% |
| Total Group | 320.9 | 304.5 | 5.4% |
| 12-month | |||
|---|---|---|---|
| 12-month | December 2023 | Change | |
| EBITDA margin1 | December 2024 | Unaudited | bps |
| ARYZTA Europe | 14.0% | 13.0% | 100 bps |
| ARYZTA Rest of World | 19.8% | 20.6% | (80) bps |
| Total Group | 14.6% | 13.9% | 70 bps |
1 See glossary on slide 42 for definitions of financial terms and references.

| 12-month | ||
|---|---|---|
| 12-month | December 2023 | |
| in €m | December 2024 | Unaudited |
| EBITDA | 320.9 | 304.5 |
| Working capital movement | 31.1 | 27.4 |
| Working capital movement from debtor securitisation | 3.0 | 8.8 |
| Capital expenditure | (94.3) | (69.0) |
| Net payments on lease contracts | (37.9) | (35.9) |
| Proceeds from sale of fixed assets | 0.9 | 4.1 |
| Restructuring-related cash flows | (0.4) | (2.9) |
| Dividends paid on hybrid instruments | (34.7) | (54.6) |
| Interest and income tax paid, net | (56.6) | (49.8) |
| Other | 5.8 | (0.2) |
| Free cash flow | 137.8 | 132.4 |

| Average | Average | ||
|---|---|---|---|
| December | December | ||
| Currency | 2024 | 2023 | % Change |
| CHF | 0.9525 | 0.9732 | 2.1% |
| AUD | 1.6397 | 1.5958 | (2.8%) |
| GBP | 0.8468 | 0.8685 | 2.5% |
| PLN | 4.3060 | 4.5977 | 6.3% |
| Closing | Closing | ||
|---|---|---|---|
| December | December | ||
| Currency | 2024 | 2023 | % Change |
| CHF | 0.9398 | 0.9332 | (0.7%) |
| AUD | 1.6756 | 1.6185 | (3.5%) |
| GBP | 0.8292 | 0.8688 | 4.6% |
| PLN | 4.2763 | 4.3382 | 1.4% |

'Organic growth' – represents the revenue growth during the period, after removing the impact of acquisitions and divestures and foreign exchange translation. This provides a "like-for-like" comparison with the previous period in constant scope and constant currency.
'EBITDA' – presented as earnings before interest, taxation, depreciation and amortisation. In the 2022 Annual Report and Accounts this was referred to as 'IFRS EBITDA'.
'Free cash flow' – represents the company's ability to generate free funds from its operating activities after its investments in fixed assets and repayments of lease liabilities. It is calculated as net cash flows from operating activities per the IFRS cash flow statement, adjusted for cash flows related to the purchase of property, plant and equipment and intangible assets, proceeds from sale of property plant and equipment, lease principal payments and dividends paid on hybrid instruments.
'Net debt' – is defined as the Group's interest bearing loans and bonds and lease liabilities, after deduction of cash and cash equivalents.
'Hybrid instrument' – presented as Perpetual Callable Subordinated Instruments, which have no contractual maturity date and for which the Group controls the timing of settlement; therefore, these instruments are accounted for as equity instruments in accordance with IAS 32 'Financial Instruments'.
'Net working capital' – comprises inventory, trade and other receivables and trade and other payables.
'Invested capital' – Excludes financial assets at fair value, bank debt, cash and cash equivalents and tax balances. Invested capital is a measure of the operational net assets used to generate the results of the business, excluding financing, tax and cash-management activities.
'NOPAT' – Net operating profit after tax. This is operating profit after a normalised tax rate of 25%, before gains/losses on disposal of businesses excluding taxation directly attributable to disposal of businesses.
'ROIC' – Return On Invested Capital is a measure of performance which integrates both measures of profitability and measures of capital efficiency. This is calculated as trailing twelve month NOPAT divided by average Invested capital, as at the beginning and the end of the financial period.
Please refer to Alternative Performance Measures on pages 243 - 246 of the Annual Report December 2024 for definitions and reconciliation with related IFRS measures.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.